Business
Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel
CARMEL, Ind. & LONDON, December 04, 2025--Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel
About this update from Glaukos Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":232,"url":"https://media.zenfs.com/en/business-wire.com/0be4145aae162f11d67f14b327351b15"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/eOosgYisA1gtLzUpfee20w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ2NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0be4145aae162f11d67f14b327351b15","width":480,"height":232},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/PYtQH6DYenRLJiybK1gosw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMwOTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0be4145aae162f11d67f14b327351b15","width":480,"height":232}},"lazy":false},{"type":"text","content":"CARMEL, Ind. & LONDON, December 04, 2025--(BUSINESS WIRE)--Sudo Biosciences, ("Sudo"), a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the appointment of Paul S. Bavier, J.D., as Chief Legal Officer.","length":308,"tagName":"p"},{"type":"text","content":"Mr. Bavier brings more than two decades of legal and executive leadership experience in the biotechnology industry, with deep expertise spanning company formation, financings, mergers and acquisitions, compliance, and public market readiness.","length":242,"tagName":"p"},{"type":"text","content":"Before joining Sudo, Mr. Bavier served as General Counsel, Secretary and Chief Administrative Officer at HilleVax, Inc., where he was a founding member of the leadership team and helped guide the company through its initial public offering and clinical development milestones. He previously served as General Counsel at VelosBio, Inc. (acquired by Merck & Co.) and Avedro, Inc. (acquired by Glaukos Corporation), where he led corporate governance, compliance, and strategic initiatives. Earlier in his career, he served as General Counsel and Vice President of Corporate Development at Biodel, Inc. Mr. Bavier began his legal career at Ropes & Gray LLP.","length":661,"tagName":"p"},{"type":"text","content":""Paul’s deep experience across the biotech lifecycle—from company formation through IPO and acquisition—makes him an outstanding addition to Sudo’s leadership team," said Scott Byrd, Chief Executive Officer of Sudo Biosciences. "His prov...